NL7300873A - - Google Patents

Info

Publication number
NL7300873A
NL7300873A NL7300873A NL7300873A NL7300873A NL 7300873 A NL7300873 A NL 7300873A NL 7300873 A NL7300873 A NL 7300873A NL 7300873 A NL7300873 A NL 7300873A NL 7300873 A NL7300873 A NL 7300873A
Authority
NL
Netherlands
Application number
NL7300873A
Other versions
NL175410B (nl
NL175410C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22829539&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL7300873(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NL7300873A publication Critical patent/NL7300873A/xx
Publication of NL175410B publication Critical patent/NL175410B/xx
Application granted granted Critical
Publication of NL175410C publication Critical patent/NL175410C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NLAANVRAGE7300873,A 1972-01-28 1973-01-22 Werkwijze voor het vervaardigen van een farmaceutisch preparaat met antihistaminische, bronchodilatoire en antiallergische werking, daarmee verkregen gevormde farmaceutische preparaten, en werkwijze voor het bereiden van een verbinding geschikt voor toepassing bij voornoemde werkwijze. NL175410C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22182172A 1972-01-28 1972-01-28

Publications (3)

Publication Number Publication Date
NL7300873A true NL7300873A (zh) 1973-07-31
NL175410B NL175410B (nl) 1984-06-01
NL175410C NL175410C (nl) 1984-11-01

Family

ID=22829539

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7300873,A NL175410C (nl) 1972-01-28 1973-01-22 Werkwijze voor het vervaardigen van een farmaceutisch preparaat met antihistaminische, bronchodilatoire en antiallergische werking, daarmee verkregen gevormde farmaceutische preparaten, en werkwijze voor het bereiden van een verbinding geschikt voor toepassing bij voornoemde werkwijze.

Country Status (26)

Country Link
JP (1) JPS5115035B2 (zh)
AR (1) AR195314A1 (zh)
AT (2) AT321917B (zh)
AU (1) AU467361B2 (zh)
BE (1) BE794597A (zh)
CA (1) CA978946A (zh)
CH (2) CH587820A5 (zh)
CS (1) CS177834B2 (zh)
DD (1) DD103239A5 (zh)
DE (1) DE2303306C3 (zh)
DK (1) DK136713B (zh)
ES (1) ES410731A1 (zh)
FR (1) FR2181690B1 (zh)
GB (1) GB1413138A (zh)
HU (1) HU166477B (zh)
IE (1) IE36983B1 (zh)
IL (1) IL41060A (zh)
LU (1) LU66916A1 (zh)
NL (1) NL175410C (zh)
NO (1) NO140057C (zh)
PH (1) PH10264A (zh)
PL (1) PL89095B1 (zh)
SE (1) SE382058B (zh)
SU (1) SU464997A3 (zh)
YU (1) YU36013B (zh)
ZA (1) ZA728544B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941795A (en) 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
IT1200123B (it) * 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
JPS63101760U (zh) * 1986-12-19 1988-07-02
IT1205685B (it) * 1987-05-26 1989-03-31 Erregierre Spa Processo per la preparazione di alfa-(alchilfenil)-4-(idrossi difenilmetil)-1-piperidina butanolo
ZA901360B (en) * 1989-02-28 1990-11-28 Merrell Dow Pharma Preparation of the low-melting polymorphic form of terfenadine
ZA903145B (en) * 1989-05-01 1991-02-27 Merrell Dow Pharma Process for the preparation of the high melting polymorphic form of terfenadine
DE3917241A1 (de) * 1989-05-26 1990-11-29 Schaper & Bruemmer Gmbh 4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
US5466691A (en) * 1991-08-09 1995-11-14 Yoshitomi Pharmaceutical Industries, Ltd. Thiophene compound
WO1996035667A1 (en) * 1995-05-08 1996-11-14 Hoescht Marion Roussel, Inc. Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
ATE260983T1 (de) * 1997-03-11 2004-03-15 Aventis Pharma Inc Verfahren zur herstellung von 4-(4-(4- (hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl - alpha,alpha-dimenthylphenylessigsäure und phosphorylierter derivate
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
WO2006043691A1 (ja) * 2004-10-18 2006-04-27 Reverse Proteomics Research Institute Co., Ltd. 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081303A (en) * 1961-10-13 1963-03-12 Searle & Co 1-aminoalkyl-alpha, alpha-diphenylpiperidine-methanols
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives

Also Published As

Publication number Publication date
IE36983B1 (en) 1977-04-13
BE794597A (fr) 1973-05-16
CA978946A (en) 1975-12-02
GB1413138A (en) 1975-11-05
FR2181690B1 (zh) 1976-05-14
NO140057B (no) 1979-03-19
PH10264A (en) 1976-10-20
IE36983L (en) 1973-07-28
HU166477B (zh) 1975-03-28
NO140057C (no) 1979-07-04
FR2181690A1 (zh) 1973-12-07
YU3473A (en) 1981-02-28
DK136713C (zh) 1978-05-01
JPS5115035B2 (zh) 1976-05-13
SE382058B (sv) 1976-01-12
JPS4885578A (zh) 1973-11-13
AT323742B (de) 1975-07-25
AR195314A1 (es) 1973-09-28
LU66916A1 (zh) 1973-07-27
ES410731A1 (es) 1976-04-01
YU36013B (en) 1981-11-13
DE2303306B2 (de) 1978-09-28
DE2303306C3 (de) 1979-05-31
NL175410B (nl) 1984-06-01
AT321917B (de) 1975-04-25
IL41060A (en) 1975-06-25
SU464997A3 (ru) 1975-03-25
DE2303306A1 (de) 1973-08-02
IL41060A0 (en) 1973-02-28
ZA728544B (en) 1974-02-27
DK136713B (da) 1977-11-14
AU467361B2 (en) 1975-11-27
NL175410C (nl) 1984-11-01
PL89095B1 (zh) 1976-10-30
DD103239A5 (zh) 1974-01-12
CS177834B2 (zh) 1977-08-31
AU4989372A (en) 1974-06-13
CH593259A5 (zh) 1977-11-30
CH587820A5 (zh) 1977-05-13

Similar Documents

Publication Publication Date Title
CS171274B2 (zh)
JPS5237801B2 (zh)
FR2179427A5 (zh)
FR2207183A1 (zh)
DK136312C (zh)
FR2181690B1 (zh)
JPS48104336A (zh)
JPS4926348A (zh)
JPS504058A (zh)
JPS5311895Y2 (zh)
JPS5228323B2 (zh)
JPS4893244U (zh)
JPS4892647A (zh)
FR2195028A1 (zh)
CH564392A5 (zh)
CH572682A5 (zh)
CH589413A5 (zh)
CH572363A5 (zh)
CH572102A5 (zh)
CH569076A5 (zh)
CH567798A5 (zh)
CH566825A (zh)
CH565301A5 (zh)
CH572737A5 (zh)
CH565246A5 (zh)

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: MERRELL DOW PHARMACEUTICALS INC.

V4 Discontinued because of reaching the maximum lifetime of a patent